You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biochemical Relapsed Prostate Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Biochemical Recurrence Trial in Nanjing (Rezvilutamide, Androgen deprivation therapy (ADT), SRT)

Recruiting
  • Prostate Cancer
  • Biochemical Recurrence
  • Nanjing, Jiangsu, China
  • +1 more
Mar 2, 2023

Prostate Cancer Trial in Myrtle Beach (ChAdOx1-PCAQ, MVA-PCAQ)

Recruiting
  • Prostate Cancer
  • ChAdOx1-PCAQ
  • MVA-PCAQ
  • Myrtle Beach, South Carolina
    Carolina Urologic Research Center
Jan 30, 2023

Prostate Cancer Trial in Portland (Fluciclovine PET/CT)

Not yet recruiting
  • Prostate Cancer
  • Fluciclovine PET/CT
  • Portland, Oregon
    Oreogn Health & Science University
Feb 1, 2023

Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,

Not yet recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • +2 more
  • Changsha, China
  • +5 more
Apr 26, 2023

Prostate Cancer Recurrent Trial in Tuebingen (CC-1 Infusion)

Recruiting
  • Prostate Cancer Recurrent
  • CC-1 Infusion
  • Tuebingen, Germany
    University Hospital Tuebingen
Jan 10, 2023

Prostate Cancer Trial in Milwaukee (Pacritinib)

Recruiting
  • Prostate Cancer
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jul 18, 2022

Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],

Recruiting
  • Urologic Cancer
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Pembrolizumab Injection [Keytruda]
  • Salvage Radiation Therapy (SRT)
  • Freiburg, Baden-Württemberg, Germany
    Clinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022

Prostate Cancer Trial ([18F]-PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • [18F]-PSMA-1007
  • (no location specified)
Jan 30, 2023

Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)

Not yet recruiting
  • Prostate Cancer
  • +5 more
  • Radiopharmaceutical 18F-JK-PSMA-7
  • Radiopharmaceutical 18F-Fluorocholine
  • (no location specified)
Nov 17, 2022

Biochemical Recurrence of Malignant Tumor of Prostate Trial (64Cu-SAR-BBN)

Recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Duarte, California
  • +7 more
Jan 15, 2023

Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • triptorelin, goserelin, leuprorelin
  • (no location specified)
Mar 10, 2023

Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)

Recruiting
  • Biochemical Recurrent Prostate Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Atlanta, Johns Creek (drug, other, procedure)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Atlanta, Georgia
  • +3 more
Mar 9, 2023

Prostate Cancer Trial in Lexington (ArtemiCoffee)

Not yet recruiting
  • Prostate Cancer
  • Lexington, Kentucky
    University of Kentucky
Jul 25, 2022

Biochemical Recurrence of Malignant Tumor of Prostate Trial in United States (64Cu-SAR-bisPSMA)

Recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Los Angeles, California
  • +5 more
Jun 21, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Metastatic Trial in Ann Arbor (68Ga-PSMA)

Active, not recruiting
  • Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan
Mar 10, 2022

Prostate Adenocarcinoma Trial (68Ga-PSMA-11)

Available
  • Prostate Adenocarcinoma
  • (no location specified)
Jun 10, 2022

Cancer of Prostate Trial in Bethesda, Philadelphia (Observation and Bicalutamide, Metformin and Bicalutamide)

Completed
Has Results
  • Cancer of Prostate
  • Observation and Bicalutamide
  • Metformin and Bicalutamide
  • Bethesda, Maryland
  • +1 more
Mar 2, 2022

Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los

Terminated
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022

Immune Profiling After HDR in Local Relapsed Prostate Cancer

Completed
  • Prostate Cancer
  • PD-L1
  • HDR salvage brachytherapy
  • Maastricht, Netherlands
    Maastro
May 19, 2022

Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)

Approved for marketing
  • Prostatic Neoplasms
  • +4 more
  • 68GA PSMA-HBED-CC
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 11, 2022

Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority

Recruiting
  • Prostate Cancer
  • +2 more
  • Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
  • +7 more
  • Quebec, Canada
    CHUdeQuebec
Apr 7, 2023

Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Metastatic to Bone Trial in Dallas (68Ga PSMA-11 injection,

Recruiting
  • Prostate Cancer
  • +2 more
  • 68Ga PSMA-11 injection
  • Positron Emission Tomography/Computed Tomography
  • Dallas, Texas
    UT Southwestern Medical Center
Feb 3, 2022

Prostate Cancer Patients With Biochemical Recurrence

Active, not recruiting
  • Patients With Prostate Cancer
  • Pelvic CT or MRI + MDP bone scan + or - 18F-NaF PET/CT(SOC)
  • Saint Louis, Missouri
    John Cochran VA Medical Center St. Louis
May 10, 2022

Molecular Forms of PSA and Human Kallikrein 2 inCohort of

Active, not recruiting
  • Prostate Cancer
  • blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 1, 2022